[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601302":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":40,"collaborators":10,"id":44,"slug":10,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":10,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":10,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"The General Authority for Teaching Hospitals and Institutes","NETWORK",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Study group",null,"Patients who are scheduled for magnetic resonance cholangiopancreatography and have undergone conventional imaging",[13],"Other: Magnetic Resonance Cholangiopancreatography",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":10},"OTHER","Magnetic Resonance Cholangiopancreatography",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Hekmat S Baumey, MD","CONTACT","00201555433546","hekmattsamir@gmail.com",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"General Authority for Teaching Hospitals and Institutes","RECRUITING","Cairo","Egypt","EG",{"type":33,"coordinates":34},"Point",[35,36],31.24967,30.06263,{"lat":36,"lon":35},[39],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Hekmat Samir Baumey","Lecturer of Diagnostic Radiology, Damnhour National Medical Institute","100601302",false,"NCT07108725","Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction","The Role of Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction","Inclusion Criteria:\n\n* Adult patients (≥18 years) with clinically suspected biliary obstruction (e.g., jaundice, elevated liver enzymes, cholestasis).\n* Patients who are scheduled for magnetic resonance cholangiopancreatography (MRCP) and have undergone conventional imaging \\[ultrasound or computed tomography (CT)\\].\n* Patients who will undergo further invasive procedures, e.g., endoscopic retrograde cholangiopancreatography (ERCP), biopsy.\n\nExclusion Criteria:\n\n* Patients with contraindications to magnetic resonance imaging (MRI) (e.g., pacemakers, metal implants).\n* Patients who have previously undergone major biliary surgery or stent placement.\n* Pregnant or lactating women.","ALL","18 Years",{"count":53,"type":54},100,"ESTIMATED","OBSERVATIONAL","This study aims to evaluate the diagnostic value of non-invasive diffusion-weighted magnetic resonance imaging (DW-MRI) in detecting neoplastic biliary obstruction.",[58,17,59,60],"Non-invasive Diffusion-weighted Imaging","Diagnosis","Neoplastic Biliary Obstruction","2025-07-31",{"date":63,"type":64},"2025-08-07","ACTUAL",{"date":66,"type":64},"2025-05-01",{"date":68,"type":54},"2025-12-01",{"name":5,"class":6},1]